Document is current
Any future updates will be listed below
-
Authors
Zampieri, Fernando G.
Bagshaw, Sean M. https://orcid.org/0000-0003-3633-6596
Njimi, Hassane
Vincent, Jean-Louis
DeBacker, Daniel https://orcid.org/0000-0001-9841-5762
,
Biston, P.
Devriendt, J.
Madl, C.
Chochrad, D.
Aldecoa, C.
Brasseur, A.
Defrance, P.
Gottignies, P.
Kitzberger, R.
Holzinger, U.
Roman, A.
De Bels, D.
Anane, S.
Brimioulle, S.
Van Nuffelen, M.
VanCutsem, M.
Rico, J.
Gomez Herreras, J. I.
Mélot, C.
- License Information
-
More Information
Article History
Received: 23 May 2024
Accepted: 2 July 2024
First Online: 10 September 2024
Declarations
:
: This analysis was made based on fully anonymized secondary analysis of SOAP II trial provided by the investigators; no new data except from the data already available from the trial was used. SOAP II study was approved by local ethics committees at enrolling sites.
: Prof Jean-Louis Vincent is Critical Care´s journal editor. FGZ has received personal consulting fees from Baxter and Bactiguard (Sweden), unrelated to the scope of this article.
